1-benzyl-N-(methylsulfonyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

ID: ALA4638403

Chembl Id: CHEMBL4638403

PubChem CID: 156011309

Max Phase: Preclinical

Molecular Formula: C18H16N2O4S

Molecular Weight: 356.40

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)NC(=O)c1cn(Cc2ccccc2)c2ccccc2c1=O

Standard InChI:  InChI=1S/C18H16N2O4S/c1-25(23,24)19-18(22)15-12-20(11-13-7-3-2-4-8-13)16-10-6-5-9-14(16)17(15)21/h2-10,12H,11H2,1H3,(H,19,22)

Standard InChI Key:  UQCCORXJFJYNJO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4638403

    ---

Associated Targets(non-human)

Akr1b1 Aldose reductase (4007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Akr1a1 Aldehyde reductase (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 356.40Molecular Weight (Monoisotopic): 356.0831AlogP: 1.74#Rotatable Bonds: 4
Polar Surface Area: 85.24Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.93CX Basic pKa: 0.45CX LogP: 1.77CX LogD: 0.83
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.77Np Likeness Score: -1.06

References

1. Han Z, Zhu J, Zhang Y, Zhang Y, Zhang H, Qi G, Zhu C, Hao X..  (2020)  Novel quinolin-4(1H)-one derivatives as multi-effective aldose reductase inhibitors for treatment of diabetic complications: Synthesis, biological evaluation, and molecular modeling studies.,  30  (9): [PMID:32192796] [10.1016/j.bmcl.2020.127101]

Source